S0225 Capecitabine in Treating Patients Who Have Undergone Surgery for Locally Recurrent or Persistent Head and Neck Cancer
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as capecitabine, work in different ways to stop
tumor cells from dividing so they stop growing or die. Giving capecitabine after surgery may
kill any remaining tumor cells.
PURPOSE: This phase II trial is studying how well capecitabine works in treating patients who
have undergone surgery for locally recurrent or persistenthead and neck cancer.